BioCentury
ARTICLE | Company News

Discovery Laboratories sales and marketing update

November 18, 2013 8:00 AM UTC

Discovery Labs launched Surfaxin lucinactant in the U.S. to prevent respiratory distress syndrome (RDS) in premature infants. The product has a wholesale acquisition price of $860 for an 8.5 mL vial....